What Are the Current Standards of Care and Recent Developments in the Management of Breast Cancer?

David Cameron, Richard Bell, Matti Aapro, Christoph Zielinski
The Oncologist 2006; 11(Supplement 1 ): 1-3; doi:10.1634/theoncologist.11-90001-1
[Full Text] [PDF]  

Adjuvant Trastuzumab: A Milestone in the Treatment of HER-2-Positive Early Breast Cancer

José Baselga, Edith A. Perez, Tadeusz Pienkowski, Richard Bell
The Oncologist 2006; 11(Supplement 1 ): 4-12; doi:10.1634/theoncologist.11-90001-4
[Abstract] [Full Text] [PDF]  

The Role of Bisphosphonates in Early Breast Cancer

Alexander H.G. Paterson
The Oncologist 2006; 11(Supplement 1 ): 13-19; doi:10.1634/theoncologist.11-90001-13
[Abstract] [Full Text] [PDF]  

Capecitabine: Expanding Options for the Treatment of Patients with Early or Locally Advanced Breast Cancer

Andrew Wardley
The Oncologist 2006; 11(Supplement 1 ): 20-26; doi:10.1634/theoncologist.11-90001-20
[Abstract] [Full Text] [PDF]  

Ibandronate: Its Role in Metastatic Breast Cancer

David Cameron, Marie Fallon, Ingo Diel
The Oncologist 2006; 11(Supplement 1 ): 27-33; doi:10.1634/theoncologist.11-90001-27
[Abstract] [Full Text] [PDF]  

HER-2-Positive Metastatic Breast Cancer: Optimizing Trastuzumab-Based Therapy

Christian Jackisch
The Oncologist 2006; 11(Supplement 1 ): 34-41; doi:10.1634/theoncologist.11-90001-34
[Abstract] [Full Text] [PDF]  

The Role of Capecitabine in First-Line Treatment for Patients with Metastatic Breast Cancer

Karen Gelmon, Arlene Chan, Nadia Harbeck
The Oncologist 2006; 11(Supplement 1 ): 42-51; doi:10.1634/theoncologist.11-90001-42
[Abstract] [Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.